isirv
CONTACT US
MEMBER LOGIN
HOME
ABOUT
About ISIRV – Overview
Organization
Council Members
Contact ISIRV
PAST EVENTS
Past ISIRV Events
SCHOOL OF INFLUENZA
School of 2018
School of 2016
LINKS
Links
SPECIAL INTERESTS
Antiviral Group
Epidemiology Group
Neglected Influenza Viruses
Respiratory Pathogens
RSV Society
MEMBERSHIP
ISIRV Membership
Join Us
Member Login
Skip to content
About
Guides
FAQs
Font Size
Increase font size
Decrease font size
Default font size
SCREEN
Wide (default)
Fluid
Narrow
Profile
default
orange
red
Direction
LTR
RTL
Menu Style
Mega
Css
Dropline
Split
Apply
Reset
isirv
Antiviral Group
Home
About AVG
AVG - Overview, Committee
AVG Membership
Antivirals
Antiviral Overview
Influenza
SARS-CoV-2 Antivirals
Other Respiratory Viruses
Clinical
Clinical Overview
Clinical Guidance
Clinical Trials
Resistance
Resistance Overview
Monitoring
Mechanisms of Resistance
Methodology
NAI assay (IC50)
Analysis of IC50 data
Pyrosequencing
Plaque Reduction Assay
FAQ on resistance methodology
Obtaining NAI drugs for testing
Reference Panel
Mutant Characteristics
Animal Studies
Frequently Asked Questions
Education
Teaching Resources
Publications
Meeting Reports
Training
News
Events
News
Events
News
| Print |
Q3 / 2022
Q2 / 2022
Q1 / 2022
Q1 / 2021
Q3 / 2019
Q2 / 2019
Top
Skip to content
